Tokio Marine Asset Management Co. Ltd. Purchases 87 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Tokio Marine Asset Management Co. Ltd. grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,435 shares of the company’s stock after buying an additional 87 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in HCA Healthcare were worth $1,200,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Parkside Financial Bank & Trust raised its stake in shares of HCA Healthcare by 8.2% during the fourth quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock valued at $125,000 after acquiring an additional 35 shares during the last quarter. Wedmont Private Capital increased its stake in shares of HCA Healthcare by 1.6% during the fourth quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock valued at $711,000 after buying an additional 39 shares during the period. Creative Financial Designs Inc. ADV lifted its stake in HCA Healthcare by 19.9% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 253 shares of the company’s stock worth $68,000 after acquiring an additional 42 shares during the period. Huntington National Bank boosted its stake in shares of HCA Healthcare by 0.4% during the 3rd quarter. Huntington National Bank now owns 11,206 shares of the company’s stock valued at $2,756,000 after purchasing an additional 44 shares in the last quarter. Finally, Perigon Wealth Management LLC lifted its holdings in HCA Healthcare by 2.6% in the fourth quarter. Perigon Wealth Management LLC now owns 1,759 shares of the company’s stock worth $476,000 after buying an additional 44 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

HCA Healthcare stock traded down $11.01 during midday trading on Friday, hitting $303.11. The stock had a trading volume of 580,700 shares, compared to its average volume of 1,085,581. The company has a market capitalization of $80.17 billion, a PE ratio of 16.55, a P/E/G ratio of 1.54 and a beta of 1.65. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $335.83. The firm’s fifty day moving average is $324.24 and its two-hundred day moving average is $294.45. The company has a current ratio of 1.18, a quick ratio of 1.02 and a debt-to-equity ratio of 35.07.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.01 by $0.35. The business had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The firm’s revenue for the quarter was up 11.2% compared to the same quarter last year. During the same quarter last year, the business posted $4.93 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 20.58 EPS for the current year.

HCA Healthcare declared that its Board of Directors has initiated a share buyback plan on Tuesday, January 30th that allows the company to repurchase $6.00 billion in shares. This repurchase authorization allows the company to repurchase up to 7.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s leadership believes its stock is undervalued.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.87%. HCA Healthcare’s dividend payout ratio is presently 13.91%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Chad J. Wasserman sold 876 shares of HCA Healthcare stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total value of $289,299.00. Following the completion of the transaction, the senior vice president now directly owns 1,576 shares in the company, valued at $520,474. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, SVP Chad J. Wasserman sold 876 shares of the company’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total transaction of $289,299.00. Following the sale, the senior vice president now directly owns 1,576 shares in the company, valued at $520,474. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 3,200 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $306.79, for a total transaction of $981,728.00. Following the transaction, the executive vice president now owns 24,929 shares of the company’s stock, valued at approximately $7,647,967.91. The disclosure for this sale can be found here. Insiders sold a total of 14,840 shares of company stock valued at $4,588,869 in the last three months. 1.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

HCA has been the topic of several research reports. Deutsche Bank Aktiengesellschaft lifted their price target on HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research report on Friday, April 12th. Sanford C. Bernstein lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating and increased their price target for the stock from $277.00 to $301.00 in a research note on Thursday, January 4th. Truist Financial raised their target price on shares of HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Wells Fargo & Company upped their price target on HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 28th. Finally, Raymond James boosted their target price on HCA Healthcare from $300.00 to $330.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Four research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $310.88.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.